公司简介

Skyhawk's is developing small molecule therapeutics that correct RNA expression.Their proprietary technology enables the rational design of small molecules that target the RNA splicing process.They are now developing drug candidates for cancer, neurological disease, and rare disease.

产品/服务

融资信息

融资轮次	融资日期	投资方	融资额度
A轮	2018-06	Alexandria Venture Investments、Duke of Bedford	4000万美元

关联公司